

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | skin morphogenesis (GO:0043589) | 6.81860119 |
| 2 | membrane raft organization (GO:0031579) | 6.48404634 |
| 3 | lung vasculature development (GO:0060426) | 5.91352910 |
| 4 | positive regulation of vesicle fusion (GO:0031340) | 5.89704720 |
| 5 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 5.69199223 |
| 6 | facial nerve structural organization (GO:0021612) | 5.55540995 |
| 7 | substrate-dependent cell migration (GO:0006929) | 5.43553045 |
| 8 | cell adhesion mediated by integrin (GO:0033627) | 5.40635364 |
| 9 | ganglion development (GO:0061548) | 4.91063061 |
| 10 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.88738236 |
| 11 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 4.83691839 |
| 12 | wound healing, spreading of epidermal cells (GO:0035313) | 4.72831517 |
| 13 | membrane assembly (GO:0071709) | 4.72160478 |
| 14 | morphogenesis of an endothelium (GO:0003159) | 4.47506454 |
| 15 | endothelial tube morphogenesis (GO:0061154) | 4.47506454 |
| 16 | protein localization to endosome (GO:0036010) | 4.47269060 |
| 17 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 4.45051394 |
| 18 | membrane budding (GO:0006900) | 4.34463157 |
| 19 | negative regulation of protein autophosphorylation (GO:0031953) | 4.26821746 |
| 20 | glomerular visceral epithelial cell development (GO:0072015) | 4.24313059 |
| 21 | muscle cell migration (GO:0014812) | 4.21650673 |
| 22 | hepatocyte differentiation (GO:0070365) | 3.99952864 |
| 23 | protein heterotetramerization (GO:0051290) | 3.92704903 |
| 24 | endothelial cell chemotaxis (GO:0035767) | 3.91948410 |
| 25 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.85013328 |
| 26 | hemidesmosome assembly (GO:0031581) | 3.81323967 |
| 27 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 3.80705647 |
| 28 | Golgi transport vesicle coating (GO:0048200) | 3.79343571 |
| 29 | COPI coating of Golgi vesicle (GO:0048205) | 3.79343571 |
| 30 | axon extension involved in axon guidance (GO:0048846) | 3.75638411 |
| 31 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.75638411 |
| 32 | fibrinolysis (GO:0042730) | 3.72984096 |
| 33 | mesodermal cell differentiation (GO:0048333) | 3.72980226 |
| 34 | renal filtration (GO:0097205) | 3.67182743 |
| 35 | negative regulation of anoikis (GO:2000811) | 3.64632185 |
| 36 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.64207926 |
| 37 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.63267049 |
| 38 | glomerular epithelial cell development (GO:0072310) | 3.61642178 |
| 39 | cranial nerve structural organization (GO:0021604) | 3.54488097 |
| 40 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.51347083 |
| 41 | barbed-end actin filament capping (GO:0051016) | 3.38764597 |
| 42 | establishment of integrated proviral latency (GO:0075713) | 3.36834575 |
| 43 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 3.35394876 |
| 44 | lung epithelium development (GO:0060428) | 3.31967117 |
| 45 | wound healing, spreading of cells (GO:0044319) | 3.30210159 |
| 46 | endothelial cell morphogenesis (GO:0001886) | 3.26279167 |
| 47 | regulation of smooth muscle cell apoptotic process (GO:0034391) | 3.25319994 |
| 48 | blood vessel maturation (GO:0001955) | 3.25302102 |
| 49 | regulation of protein kinase A signaling (GO:0010738) | 3.23993080 |
| 50 | type B pancreatic cell proliferation (GO:0044342) | 3.20106837 |
| 51 | regulation of metalloenzyme activity (GO:0048552) | 3.16372220 |
| 52 | semaphorin-plexin signaling pathway (GO:0071526) | 3.12893391 |
| 53 | actin filament depolymerization (GO:0030042) | 3.09198337 |
| 54 | establishment of viral latency (GO:0019043) | 3.07675513 |
| 55 | regulation of interleukin-8 secretion (GO:2000482) | 3.07425507 |
| 56 | protein maturation by protein folding (GO:0022417) | 3.05612373 |
| 57 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.97944374 |
| 58 | regulation of anoikis (GO:2000209) | 2.89725974 |
| 59 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.88532065 |
| 60 | lipopolysaccharide metabolic process (GO:0008653) | 2.85316305 |
| 61 | membrane protein ectodomain proteolysis (GO:0006509) | 2.85258190 |
| 62 | protein hydroxylation (GO:0018126) | 2.84140957 |
| 63 | glomerular filtration (GO:0003094) | 2.83268721 |
| 64 | complement activation, classical pathway (GO:0006958) | 2.81584379 |
| 65 | negative regulation of receptor activity (GO:2000272) | 2.78477250 |
| 66 | SMAD protein complex assembly (GO:0007183) | 2.78215562 |
| 67 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.77734042 |
| 68 | nuclear envelope reassembly (GO:0031468) | 2.77589855 |
| 69 | mitotic nuclear envelope reassembly (GO:0007084) | 2.77589855 |
| 70 | retinal metabolic process (GO:0042574) | 2.77290468 |
| 71 | diterpenoid biosynthetic process (GO:0016102) | 2.77053549 |
| 72 | C21-steroid hormone biosynthetic process (GO:0006700) | 2.75905014 |
| 73 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.75565630 |
| 74 | positive regulation of cartilage development (GO:0061036) | 2.74219425 |
| 75 | inositol phosphate-mediated signaling (GO:0048016) | 2.73005083 |
| 76 | sprouting angiogenesis (GO:0002040) | 2.70034117 |
| 77 | cell proliferation involved in kidney development (GO:0072111) | 2.67192931 |
| 78 | organ formation (GO:0048645) | 2.66218723 |
| 79 | lymphangiogenesis (GO:0001946) | 2.65107011 |
| 80 | regulation of chondrocyte differentiation (GO:0032330) | 2.64980334 |
| 81 | endochondral ossification (GO:0001958) | 2.64878430 |
| 82 | replacement ossification (GO:0036075) | 2.64878430 |
| 83 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.64861779 |
| 84 | regulation of receptor recycling (GO:0001919) | 2.63747920 |
| 85 | branch elongation of an epithelium (GO:0060602) | 2.59292481 |
| 86 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.59127496 |
| 87 | regulation of endothelial cell differentiation (GO:0045601) | 2.57711228 |
| 88 | regulation of vesicle fusion (GO:0031338) | 2.56954859 |
| 89 | inactivation of MAPK activity (GO:0000188) | 2.56108291 |
| 90 | eosinophil chemotaxis (GO:0048245) | 2.55345872 |
| 91 | bone remodeling (GO:0046849) | 2.54771442 |
| 92 | peptidyl-proline hydroxylation (GO:0019511) | 2.54623467 |
| 93 | coronary vasculature morphogenesis (GO:0060977) | 2.51067304 |
| 94 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.50382065 |
| 95 | response to gravity (GO:0009629) | 2.49915643 |
| 96 | positive regulation of chondrocyte differentiation (GO:0032332) | 2.49901319 |
| 97 | ear development (GO:0043583) | 2.49577860 |
| 98 | negative regulation of JAK-STAT cascade (GO:0046426) | 2.49569800 |
| 99 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.48867513 |
| 100 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.47089837 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 7.74206738 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.51090551 |
| 3 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 5.34782574 |
| 4 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 4.31270287 |
| 5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 4.05189327 |
| 6 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 3.56010550 |
| 7 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 3.46541265 |
| 8 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 3.31873493 |
| 9 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 3.31873493 |
| 10 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 3.05953364 |
| 11 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.00739318 |
| 12 | CJUN_26792858_Chip-Seq_BT549_Human | 2.89953334 |
| 13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.75725702 |
| 14 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.75006576 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.67835138 |
| 16 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.62254850 |
| 17 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.55805846 |
| 18 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.40520203 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.33588003 |
| 20 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.30159277 |
| 21 | BRD4_25478319_ChIP-Seq_HGPS_Human | 2.26426596 |
| 22 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.94522263 |
| 23 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.90057969 |
| 24 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.89182776 |
| 25 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.86877664 |
| 26 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.86825099 |
| 27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.85949226 |
| 28 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.85570720 |
| 29 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.84926625 |
| 30 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.84418018 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.82720022 |
| 32 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.82196585 |
| 33 | ATF3_27146783_Chip-Seq_COLON_Human | 1.79107298 |
| 34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.74506602 |
| 35 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.69620865 |
| 36 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.67561016 |
| 37 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.60045045 |
| 38 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.57432774 |
| 39 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.50728884 |
| 40 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.45866711 |
| 41 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.45079609 |
| 42 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.44993025 |
| 43 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.44729977 |
| 44 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.44667395 |
| 45 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.44648017 |
| 46 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.38341025 |
| 47 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.36439790 |
| 48 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.35409912 |
| 49 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.33985503 |
| 50 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.33025879 |
| 51 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.32587333 |
| 52 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.31466131 |
| 53 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.31373832 |
| 54 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.29132446 |
| 55 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.27257244 |
| 56 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.27206330 |
| 57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.25460444 |
| 58 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.25069947 |
| 59 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.24824546 |
| 60 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.24669788 |
| 61 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.20925272 |
| 62 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.20799478 |
| 63 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.19404132 |
| 64 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19040691 |
| 65 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.15818663 |
| 66 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11977160 |
| 67 | TP53_16413492_ChIP-PET_HCT116_Human | 1.11009738 |
| 68 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.08431659 |
| 69 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.08290360 |
| 70 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.07522955 |
| 71 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05569368 |
| 72 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.03955549 |
| 73 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03150546 |
| 74 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.03063903 |
| 75 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.01444678 |
| 76 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.00880008 |
| 77 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98570964 |
| 78 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98570964 |
| 79 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.98482348 |
| 80 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.98368575 |
| 81 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.98085036 |
| 82 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.98010909 |
| 83 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.93937185 |
| 84 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.91882561 |
| 85 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.90387340 |
| 86 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.90103188 |
| 87 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.87890474 |
| 88 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85802740 |
| 89 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.84424362 |
| 90 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.83422247 |
| 91 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.83388688 |
| 92 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.80656517 |
| 93 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.78973768 |
| 94 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.78038461 |
| 95 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.77862751 |
| 96 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.77772972 |
| 97 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.77387861 |
| 98 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.77215688 |
| 99 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.75968631 |
| 100 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.74949522 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004272_abnormal_basement_membrane | 5.12594453 |
| 2 | MP0003950_abnormal_plasma_membrane | 4.73001052 |
| 3 | MP0002877_abnormal_melanocyte_morpholog | 3.84388690 |
| 4 | MP0010368_abnormal_lymphatic_system | 3.77137205 |
| 5 | MP0002332_abnormal_exercise_endurance | 3.49817526 |
| 6 | MP0001879_abnormal_lymphatic_vessel | 3.14544390 |
| 7 | MP0003195_calcinosis | 3.09204594 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 2.62030626 |
| 9 | MP0003828_pulmonary_edema | 2.46082220 |
| 10 | MP0005257_abnormal_intraocular_pressure | 2.36480674 |
| 11 | MP0006082_CNS_inflammation | 2.36013054 |
| 12 | MP0006054_spinal_hemorrhage | 2.35280682 |
| 13 | MP0008438_abnormal_cutaneous_collagen | 2.19179947 |
| 14 | MP0003091_abnormal_cell_migration | 2.14404684 |
| 15 | MP0005165_increased_susceptibility_to | 2.12872692 |
| 16 | MP0003566_abnormal_cell_adhesion | 2.06846632 |
| 17 | MP0005623_abnormal_meninges_morphology | 2.03744252 |
| 18 | MP0005023_abnormal_wound_healing | 1.99783668 |
| 19 | MP0005164_abnormal_response_to | 1.99728287 |
| 20 | MP0009840_abnormal_foam_cell | 1.95230966 |
| 21 | MP0000749_muscle_degeneration | 1.94935059 |
| 22 | MP0000013_abnormal_adipose_tissue | 1.91582434 |
| 23 | MP0005084_abnormal_gallbladder_morpholo | 1.89245491 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 1.84996510 |
| 25 | MP0010234_abnormal_vibrissa_follicle | 1.83652642 |
| 26 | MP0010030_abnormal_orbit_morphology | 1.78330214 |
| 27 | MP0010352_gastrointestinal_tract_polyps | 1.71643099 |
| 28 | MP0001348_abnormal_lacrimal_gland | 1.65298559 |
| 29 | MP0005360_urolithiasis | 1.64418719 |
| 30 | MP0002933_joint_inflammation | 1.61152035 |
| 31 | MP0009697_abnormal_copulation | 1.61127339 |
| 32 | MP0001545_abnormal_hematopoietic_system | 1.50486803 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.50486803 |
| 34 | MP0002896_abnormal_bone_mineralization | 1.50111100 |
| 35 | MP0000751_myopathy | 1.48593420 |
| 36 | MP0001915_intracranial_hemorrhage | 1.46733658 |
| 37 | MP0000767_abnormal_smooth_muscle | 1.39091893 |
| 38 | MP0005197_abnormal_uvea_morphology | 1.38394464 |
| 39 | MP0004510_myositis | 1.36746678 |
| 40 | MP0000762_abnormal_tongue_morphology | 1.34146015 |
| 41 | MP0002168_other_aberrant_phenotype | 1.31520802 |
| 42 | MP0001542_abnormal_bone_strength | 1.30887818 |
| 43 | MP0000858_altered_metastatic_potential | 1.29587036 |
| 44 | MP0002060_abnormal_skin_morphology | 1.22618008 |
| 45 | MP0003315_abnormal_perineum_morphology | 1.22251653 |
| 46 | MP0000003_abnormal_adipose_tissue | 1.20624018 |
| 47 | MP0003279_aneurysm | 1.18766480 |
| 48 | MP0000343_altered_response_to | 1.18512692 |
| 49 | MP0000465_gastrointestinal_hemorrhage | 1.15933167 |
| 50 | MP0000733_abnormal_muscle_development | 1.15120673 |
| 51 | MP0003221_abnormal_cardiomyocyte_apopto | 1.14914854 |
| 52 | MP0005167_abnormal_blood-brain_barrier | 1.12671713 |
| 53 | MP0004883_abnormal_blood_vessel | 1.08220815 |
| 54 | MP0003786_premature_aging | 1.05743456 |
| 55 | MP0000750_abnormal_muscle_regeneration | 1.05092526 |
| 56 | MP0005595_abnormal_vascular_smooth | 1.02664281 |
| 57 | MP0000249_abnormal_blood_vessel | 1.00637322 |
| 58 | MP0002932_abnormal_joint_morphology | 0.99112695 |
| 59 | MP0004233_abnormal_muscle_weight | 0.99085713 |
| 60 | MP0009278_abnormal_bone_marrow | 0.95809451 |
| 61 | MP0002972_abnormal_cardiac_muscle | 0.95332319 |
| 62 | MP0001340_abnormal_eyelid_morphology | 0.95118556 |
| 63 | MP0000537_abnormal_urethra_morphology | 0.94802546 |
| 64 | MP0000613_abnormal_salivary_gland | 0.91749966 |
| 65 | MP0003385_abnormal_body_wall | 0.90712197 |
| 66 | MP0005395_other_phenotype | 0.88226196 |
| 67 | MP0001216_abnormal_epidermal_layer | 0.87895978 |
| 68 | MP0001614_abnormal_blood_vessel | 0.87838214 |
| 69 | MP0000467_abnormal_esophagus_morphology | 0.85084613 |
| 70 | MP0002233_abnormal_nose_morphology | 0.84317826 |
| 71 | MP0002295_abnormal_pulmonary_circulatio | 0.84091218 |
| 72 | MP0005193_abnormal_anterior_eye | 0.82780336 |
| 73 | MP0002177_abnormal_outer_ear | 0.82526698 |
| 74 | MP0005166_decreased_susceptibility_to | 0.80154842 |
| 75 | MP0001270_distended_abdomen | 0.76536812 |
| 76 | MP0010678_abnormal_skin_adnexa | 0.75912955 |
| 77 | MP0004947_skin_inflammation | 0.74226241 |
| 78 | MP0005621_abnormal_cell_physiology | 0.73757777 |
| 79 | MP0003252_abnormal_bile_duct | 0.72942634 |
| 80 | MP0002925_abnormal_cardiovascular_devel | 0.71748243 |
| 81 | MP0005367_renal/urinary_system_phenotyp | 0.70209378 |
| 82 | MP0000516_abnormal_urinary_system | 0.70209378 |
| 83 | MP0003075_altered_response_to | 0.69623911 |
| 84 | MP0003453_abnormal_keratinocyte_physiol | 0.69537149 |
| 85 | MP0001191_abnormal_skin_condition | 0.68346092 |
| 86 | MP0005376_homeostasis/metabolism_phenot | 0.68112058 |
| 87 | MP0003943_abnormal_hepatobiliary_system | 0.62971058 |
| 88 | MP0003755_abnormal_palate_morphology | 0.62919252 |
| 89 | MP0008873_increased_physiological_sensi | 0.62385774 |
| 90 | MP0009053_abnormal_anal_canal | 0.62181203 |
| 91 | MP0001175_abnormal_lung_morphology | 0.61809661 |
| 92 | MP0009780_abnormal_chondrocyte_physiolo | 0.60440139 |
| 93 | MP0002269_muscular_atrophy | 0.60180248 |
| 94 | MP0003123_paternal_imprinting | 0.60167870 |
| 95 | MP0000627_abnormal_mammary_gland | 0.60042605 |
| 96 | MP0001346_abnormal_lacrimal_gland | 0.59182348 |
| 97 | MP0004782_abnormal_surfactant_physiolog | 0.58566139 |
| 98 | MP0003656_abnormal_erythrocyte_physiolo | 0.58210399 |
| 99 | MP0001243_abnormal_dermal_layer | 0.57802672 |
| 100 | MP0004858_abnormal_nervous_system | 0.56547761 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Upper limb muscle weakness (HP:0003484) | 5.71015482 |
| 2 | Premature rupture of membranes (HP:0001788) | 4.27581313 |
| 3 | Conjugated hyperbilirubinemia (HP:0002908) | 3.97829254 |
| 4 | Protrusio acetabuli (HP:0003179) | 3.90486372 |
| 5 | Short nail (HP:0001799) | 3.87512786 |
| 6 | Posterior subcapsular cataract (HP:0007787) | 3.87044505 |
| 7 | Hyperkalemia (HP:0002153) | 3.75612125 |
| 8 | Male infertility (HP:0003251) | 3.69782583 |
| 9 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.67341819 |
| 10 | Osteolytic defects of the hand bones (HP:0009699) | 3.67341819 |
| 11 | Subcapsular cataract (HP:0000523) | 3.63575401 |
| 12 | Prostate neoplasm (HP:0100787) | 3.60528163 |
| 13 | Arterial tortuosity (HP:0005116) | 3.47556316 |
| 14 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.39773778 |
| 15 | Amyloidosis (HP:0011034) | 3.32529488 |
| 16 | Entropion (HP:0000621) | 3.31286547 |
| 17 | Glucose intolerance (HP:0000833) | 3.10787098 |
| 18 | Vascular calcification (HP:0004934) | 2.90465010 |
| 19 | Cervical subluxation (HP:0003308) | 2.88341728 |
| 20 | Distal lower limb amyotrophy (HP:0008944) | 2.84997970 |
| 21 | Neurofibrillary tangles (HP:0002185) | 2.84664917 |
| 22 | Vascular tortuosity (HP:0004948) | 2.83065181 |
| 23 | Broad face (HP:0000283) | 2.82375797 |
| 24 | Ulnar claw (HP:0001178) | 2.80343105 |
| 25 | Milia (HP:0001056) | 2.79727243 |
| 26 | Facial hemangioma (HP:0000329) | 2.78976942 |
| 27 | Cardiovascular calcification (HP:0011915) | 2.77591005 |
| 28 | Abnormality of the intrinsic pathway (HP:0010989) | 2.75329678 |
| 29 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.73593503 |
| 30 | Increased connective tissue (HP:0009025) | 2.72467758 |
| 31 | Abnormal platelet function (HP:0011869) | 2.70528387 |
| 32 | Impaired platelet aggregation (HP:0003540) | 2.70528387 |
| 33 | Polar cataract (HP:0010696) | 2.65364995 |
| 34 | Menorrhagia (HP:0000132) | 2.64916372 |
| 35 | Broad alveolar ridges (HP:0000187) | 2.64346959 |
| 36 | Right ventricular cardiomyopathy (HP:0011663) | 2.62610371 |
| 37 | Limb-girdle muscle atrophy (HP:0003797) | 2.61026378 |
| 38 | Distal lower limb muscle weakness (HP:0009053) | 2.55342240 |
| 39 | Spinal rigidity (HP:0003306) | 2.55061491 |
| 40 | Wormian bones (HP:0002645) | 2.52649235 |
| 41 | Wrist flexion contracture (HP:0001239) | 2.51718518 |
| 42 | Atrophic scars (HP:0001075) | 2.44734580 |
| 43 | Trismus (HP:0000211) | 2.43161732 |
| 44 | Intrahepatic cholestasis (HP:0001406) | 2.41291295 |
| 45 | Adrenal hypoplasia (HP:0000835) | 2.37608232 |
| 46 | Deviation of the thumb (HP:0009603) | 2.37190812 |
| 47 | Spondylolisthesis (HP:0003302) | 2.35537527 |
| 48 | Subacute progressive viral hepatitis (HP:0006572) | 2.29559598 |
| 49 | Aortic dissection (HP:0002647) | 2.29354070 |
| 50 | Vertebral compression fractures (HP:0002953) | 2.28782133 |
| 51 | Lower limb amyotrophy (HP:0007210) | 2.27559589 |
| 52 | Distal upper limb amyotrophy (HP:0007149) | 2.25082955 |
| 53 | Upper limb amyotrophy (HP:0009129) | 2.25082955 |
| 54 | Hand muscle atrophy (HP:0009130) | 2.21498017 |
| 55 | Cerebral inclusion bodies (HP:0100314) | 2.20778952 |
| 56 | Difficulty climbing stairs (HP:0003551) | 2.20036154 |
| 57 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.19648928 |
| 58 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.19648928 |
| 59 | Mitral stenosis (HP:0001718) | 2.17112955 |
| 60 | Joint hemorrhage (HP:0005261) | 2.16659572 |
| 61 | Microglossia (HP:0000171) | 2.10587679 |
| 62 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.10122430 |
| 63 | Poikiloderma (HP:0001029) | 2.05707970 |
| 64 | Bradycardia (HP:0001662) | 2.05110519 |
| 65 | Alopecia of scalp (HP:0002293) | 2.03930867 |
| 66 | Esophageal varix (HP:0002040) | 2.03902921 |
| 67 | Capillary hemangiomas (HP:0005306) | 2.01466237 |
| 68 | Focal segmental glomerulosclerosis (HP:0000097) | 1.99855574 |
| 69 | Shoulder girdle muscle weakness (HP:0003547) | 1.99496202 |
| 70 | Fibular aplasia (HP:0002990) | 1.97228883 |
| 71 | Myocardial infarction (HP:0001658) | 1.97094506 |
| 72 | Submucous cleft hard palate (HP:0000176) | 1.96409702 |
| 73 | Large eyes (HP:0001090) | 1.95980443 |
| 74 | Hypoplasia of the uterus (HP:0000013) | 1.94927350 |
| 75 | Tetraparesis (HP:0002273) | 1.93305232 |
| 76 | Fatigue (HP:0012378) | 1.90965681 |
| 77 | Rough bone trabeculation (HP:0100670) | 1.90850409 |
| 78 | Portal hypertension (HP:0001409) | 1.90729707 |
| 79 | Striae distensae (HP:0001065) | 1.90295404 |
| 80 | Reduced antithrombin III activity (HP:0001976) | 1.90212530 |
| 81 | Abnormal glucose tolerance (HP:0001952) | 1.89965372 |
| 82 | Sensory axonal neuropathy (HP:0003390) | 1.88698173 |
| 83 | Progressive hearing impairment (HP:0001730) | 1.88129177 |
| 84 | Onycholysis (HP:0001806) | 1.87972628 |
| 85 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.87828846 |
| 86 | Hyponatremia (HP:0002902) | 1.84775498 |
| 87 | Glomerulosclerosis (HP:0000096) | 1.84367800 |
| 88 | Pelvic girdle muscle weakness (HP:0003749) | 1.82007367 |
| 89 | Vertebral clefting (HP:0008428) | 1.81696993 |
| 90 | Xerostomia (HP:0000217) | 1.80946643 |
| 91 | Decreased motor nerve conduction velocity (HP:0003431) | 1.79906696 |
| 92 | Thick nail (HP:0001805) | 1.77181397 |
| 93 | Exercise-induced muscle cramps (HP:0003710) | 1.76611854 |
| 94 | Abnormality of the alveolar ridges (HP:0006477) | 1.75506554 |
| 95 | Hydroureter (HP:0000072) | 1.74767268 |
| 96 | Fragile skin (HP:0001030) | 1.74096610 |
| 97 | Lip pit (HP:0100267) | 1.73951354 |
| 98 | Kyphoscoliosis (HP:0002751) | 1.73935934 |
| 99 | Metaphyseal dysplasia (HP:0100255) | 1.73879363 |
| 100 | Abnormality of the hepatic vasculature (HP:0006707) | 1.73776169 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 7.85148968 |
| 2 | EPHA2 | 4.88757411 |
| 3 | MET | 3.81661538 |
| 4 | TIE1 | 3.57579316 |
| 5 | BCR | 3.20892938 |
| 6 | LMTK2 | 3.05391994 |
| 7 | ERBB4 | 2.82525184 |
| 8 | TRIM28 | 2.73364808 |
| 9 | CASK | 2.51439266 |
| 10 | TESK1 | 2.49345484 |
| 11 | IRAK3 | 2.28404655 |
| 12 | NME2 | 2.26323742 |
| 13 | TGFBR2 | 2.25899375 |
| 14 | ERBB3 | 2.13671212 |
| 15 | LIMK1 | 2.08795904 |
| 16 | PTK2 | 1.75988623 |
| 17 | CDK8 | 1.74990535 |
| 18 | SIK3 | 1.73785708 |
| 19 | EPHB2 | 1.63092375 |
| 20 | PAK4 | 1.61421785 |
| 21 | MST4 | 1.46595514 |
| 22 | MOS | 1.44515459 |
| 23 | MAP3K12 | 1.43427617 |
| 24 | MAP2K7 | 1.42334711 |
| 25 | TRPM7 | 1.39580841 |
| 26 | EPHA3 | 1.37776050 |
| 27 | TESK2 | 1.35745219 |
| 28 | MAP4K2 | 1.24652872 |
| 29 | ICK | 1.08406614 |
| 30 | STK10 | 1.05865043 |
| 31 | NTRK1 | 1.04787884 |
| 32 | EIF2AK3 | 1.03995521 |
| 33 | PDK2 | 1.02977641 |
| 34 | MAP3K6 | 1.01068323 |
| 35 | BMX | 0.98114425 |
| 36 | EIF2AK1 | 0.97220984 |
| 37 | ERN1 | 0.92905407 |
| 38 | CCNB1 | 0.89604731 |
| 39 | SCYL2 | 0.87017712 |
| 40 | ABL2 | 0.84770548 |
| 41 | NEK1 | 0.82812778 |
| 42 | TTN | 0.82370501 |
| 43 | FER | 0.80898906 |
| 44 | ARAF | 0.76400029 |
| 45 | PTK2B | 0.72333827 |
| 46 | SRPK1 | 0.69984370 |
| 47 | KDR | 0.68803046 |
| 48 | EPHB1 | 0.66738495 |
| 49 | FLT3 | 0.66235413 |
| 50 | STK38L | 0.62282505 |
| 51 | PDGFRA | 0.60239551 |
| 52 | MAP3K4 | 0.55456411 |
| 53 | BRSK1 | 0.53680273 |
| 54 | PHKG2 | 0.52646332 |
| 55 | PHKG1 | 0.52646332 |
| 56 | RIPK1 | 0.51655572 |
| 57 | STK38 | 0.51001446 |
| 58 | PRKCE | 0.50374905 |
| 59 | PIM2 | 0.50019071 |
| 60 | KSR1 | 0.48898056 |
| 61 | BUB1 | 0.45746591 |
| 62 | MYLK | 0.45467833 |
| 63 | EGFR | 0.44509079 |
| 64 | DAPK1 | 0.44126619 |
| 65 | PDGFRB | 0.40177984 |
| 66 | CSNK1A1L | 0.37241267 |
| 67 | PRKG2 | 0.37216018 |
| 68 | CSF1R | 0.35584301 |
| 69 | PRKCI | 0.35136532 |
| 70 | TNIK | 0.33988452 |
| 71 | MAP3K3 | 0.33539212 |
| 72 | CDK9 | 0.33526624 |
| 73 | VRK2 | 0.31882164 |
| 74 | PLK2 | 0.31781928 |
| 75 | IGF1R | 0.30178555 |
| 76 | NEK9 | 0.28586473 |
| 77 | MINK1 | 0.27778312 |
| 78 | MAPKAPK2 | 0.27076873 |
| 79 | BRSK2 | 0.25751983 |
| 80 | CSNK1G3 | 0.25530111 |
| 81 | MAP3K5 | 0.22594864 |
| 82 | SRC | 0.21520900 |
| 83 | GRK5 | 0.21226579 |
| 84 | PRKD2 | 0.20617652 |
| 85 | GSK3A | 0.19907046 |
| 86 | MAPK11 | 0.19586464 |
| 87 | CSNK1G1 | 0.19544181 |
| 88 | ABL1 | 0.18892499 |
| 89 | PAK6 | 0.18061585 |
| 90 | ROCK2 | 0.16889987 |
| 91 | PAK1 | 0.16879489 |
| 92 | LATS1 | 0.16267316 |
| 93 | ADRBK1 | 0.15821900 |
| 94 | ROCK1 | 0.15368395 |
| 95 | DAPK3 | 0.15365117 |
| 96 | CDK18 | 0.15297406 |
| 97 | TAOK2 | 0.15104743 |
| 98 | TBK1 | 0.14571621 |
| 99 | EIF2AK2 | 0.14456093 |
| 100 | MELK | 0.11367477 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.28877114 |
| 2 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.87002592 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 2.66483106 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.58871358 |
| 5 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.45947505 |
| 6 | Focal adhesion_Homo sapiens_hsa04510 | 2.29833237 |
| 7 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.23392196 |
| 8 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.21112218 |
| 9 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.20149769 |
| 10 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.16398305 |
| 11 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.12164246 |
| 12 | Adherens junction_Homo sapiens_hsa04520 | 2.11938435 |
| 13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.09927322 |
| 14 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.08927142 |
| 15 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.06317165 |
| 16 | Shigellosis_Homo sapiens_hsa05131 | 1.88823463 |
| 17 | Salmonella infection_Homo sapiens_hsa05132 | 1.87945295 |
| 18 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.75207405 |
| 19 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.73905555 |
| 20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.65645977 |
| 21 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.49460575 |
| 22 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.47733431 |
| 23 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.47249780 |
| 24 | Galactose metabolism_Homo sapiens_hsa00052 | 1.45668163 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.45360175 |
| 26 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.39590144 |
| 27 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.35135521 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.32530584 |
| 29 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.25590223 |
| 30 | Pertussis_Homo sapiens_hsa05133 | 1.23136738 |
| 31 | Bladder cancer_Homo sapiens_hsa05219 | 1.12714137 |
| 32 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.12675715 |
| 33 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.10480205 |
| 34 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.09972283 |
| 35 | Amoebiasis_Homo sapiens_hsa05146 | 1.09191752 |
| 36 | Protein export_Homo sapiens_hsa03060 | 1.08950728 |
| 37 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.06670811 |
| 38 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.06256871 |
| 39 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.06108047 |
| 40 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.01361695 |
| 41 | Axon guidance_Homo sapiens_hsa04360 | 1.00368101 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.98565691 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.98146710 |
| 44 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.96923306 |
| 45 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.94435245 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.93093579 |
| 47 | Apoptosis_Homo sapiens_hsa04210 | 0.91812682 |
| 48 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.91617128 |
| 49 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.90727724 |
| 50 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.89795196 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89182231 |
| 52 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.87236703 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.83825638 |
| 54 | Endocytosis_Homo sapiens_hsa04144 | 0.83280637 |
| 55 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.81804436 |
| 56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81199170 |
| 57 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.80101237 |
| 58 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78827177 |
| 59 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.78255459 |
| 60 | Hepatitis B_Homo sapiens_hsa05161 | 0.76785914 |
| 61 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.74844314 |
| 62 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72944620 |
| 63 | Legionellosis_Homo sapiens_hsa05134 | 0.70084577 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66722589 |
| 65 | Prion diseases_Homo sapiens_hsa05020 | 0.65841782 |
| 66 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.64178275 |
| 67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.63820142 |
| 68 | Tight junction_Homo sapiens_hsa04530 | 0.63517765 |
| 69 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.60196131 |
| 70 | Phagosome_Homo sapiens_hsa04145 | 0.58920315 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58505283 |
| 72 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.57027009 |
| 73 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56911853 |
| 74 | Salivary secretion_Homo sapiens_hsa04970 | 0.56066698 |
| 75 | Taste transduction_Homo sapiens_hsa04742 | 0.55413807 |
| 76 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.55140827 |
| 77 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.53607625 |
| 78 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.53558402 |
| 79 | Renin secretion_Homo sapiens_hsa04924 | 0.53334679 |
| 80 | RNA polymerase_Homo sapiens_hsa03020 | 0.52258881 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51720020 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.51237730 |
| 83 | Influenza A_Homo sapiens_hsa05164 | 0.50775984 |
| 84 | Pathways in cancer_Homo sapiens_hsa05200 | 0.50147846 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48962596 |
| 86 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.48729517 |
| 87 | Circadian rhythm_Homo sapiens_hsa04710 | 0.45317181 |
| 88 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45007714 |
| 89 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.43248074 |
| 90 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.42864001 |
| 91 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.42785697 |
| 92 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.40933708 |
| 93 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40378796 |
| 94 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39184684 |
| 95 | Lysosome_Homo sapiens_hsa04142 | 0.38096816 |
| 96 | Other glycan degradation_Homo sapiens_hsa00511 | 0.37383616 |
| 97 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.37305570 |
| 98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36839412 |
| 99 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.36664765 |
| 100 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.36025387 |

